IP Library Granted Patent US 9,250,246
Granted Patent B2
US 9,250,246 · App. 14/129,223 · Granted Feb 2, 2016

Near-infrared fluorescent dyes with large stokes shifts

Inventors: Robert Michael Strongin (Portland, OR); Martha Sibrian-Vazquez (Portland, OR); Jorge Omar Escobedo-Cordova (Portland, OR); Mark Allen Lowry (Portland, OR)
Assignee: Portland State University
G01N33/582C07D311/82C07D493/10C09B11/12C09B11/22C09B11/24G01N33/49G01N33/493Y10T436/141111
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,250,246
App. No.
14/129,223
Granted
Feb 2, 2016
Kind
B2
Abstract

Embodiments of near-infrared (NIR) dyes are disclosed, along with methods and kits for detecting analytes with the NIR dyes. The NIR dyes have a structure according to the general structure At least one of R 1 /R 2 , R 2 /R 3 , R 3 /R 4 , R 5 /R 6 , R 6 /R 7 , and/or R 7 /R 8 together forms a substituted or unsubstituted cycloalkyl or aryl.

Claims (9)

1. A compound having a chemical structure selected from

2. A method for selectively detecting an analyte in a biological fluid, comprising:

combining a compound according to claim 1 with a biological fluid to form a solution;

exposing the solution to a light source; and

detecting the analyte by detecting fluorescence from the compound.

3. The method of claim 2 where detecting fluorescence from the compound comprises detecting fluorescence at a wavelength corresponding to an emission spectrum maximum of the compound, the method further comprising quantitating the analyte by measuring an amount of fluorescence from the compound at a wavelength corresponding to an emission spectrum maximum of the compound.

4. The method of claim 2 where the biological fluid comprises blood or urine.

5. A kit for detecting an analyte, comprising at least one compound according to claim 1 , wherein the compound when combined with a sample comprising the analyte will undergo a change in its absorbance spectrum and/or emission spectrum compared to the compound in a sample that does not comprise the analyte.

6. The kit of claim 5 , further comprising at least one buffer solution in which the compound when combined with a sample comprising the analyte will undergo a change in its absorbance spectrum and/or emission spectrum compared to the compound combined with the buffer solution and a sample that does not comprise the analyte.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 8, 2016
From: PORTLAND STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038906/0154 →
ENTITY CONVERSION Recorded Nov 18, 2015
From: THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF PORTLAND STATE UNIVERSITY
To: PORTLAND STATE UNIVERSITY
Reel/Frame 037146/0065 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2014
From: STRONGIN, ROBERT MICHAEL; SIBRIAN-VAZQUEZ, MARTHA; ESCOBEDO-CORDOVA, JORGE OMAR; LOWRY, MARK ALLEN
To: THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF PORTLAND STATE UNIVERSITY
Reel/Frame 032024/0174 →
Continuity (3)
Provisional Application 61505038 · Jul 6, 2011
Provisional Application 61502839 · Jun 29, 2011
Related Publication 20140120628A1 · May 1, 2014